On the other hand, anti-BAFF monoclonal antibodies can be effective in the treatment of autoimmune pathologies (84), which could be a crucial component in lowering the risk of developing autoimmune reactions in severe COVID-19 cases. Here, TNFSF13B is linked to COVID-19.